Managing the intersection of cancer therapies and cardiovascular health, cardio-oncology has become an essential focus for healthcare providers. Treatments like chemotherapy and immunotherapy, while critical for combating cancer, can strain the heart and lead to conditions such as cardiomyopathy or arrhythmias. To address this, specialists collaborate to develop screening tools that predict risks and implement heart-protective strategies. Imaging techniques, advanced echocardiography, and biomarkers enable early detection of cardiotoxicity, ensuring timely interventions. By prioritizing the balance between effective cancer treatment and heart health, cardio-oncology aims to safeguard patients' quality of life during and beyond their cancer journey.
Title : Surgical fetal stem cells implantation in heart failure patients long term results at 14 years
Federico Benetti, Benetti Foundation, Argentina
Title : Exploring new biomarkers of cardiomyopathy
Shuping Zhong, University of Southern California, United States
Title : The development of human relaxin-2 for heart failure with preserved ejection fraction, HFpEF
Thomas Bernd Dschietzig, Relaxera GmbH & Co. KG, Germany
Title : Cancer and cardiovascular diseases: Common pathogenesis mechanisms and risk factors
Mekhman N Mamedov, National Research Center for Preventive Medicine, Russian Federation
Title : Pulse field ablation for atrial fibrillation complications: What do we know yet
Narendra Kumar, HeartbeatsZ Academy, United Kingdom
Title : Lipoprotein (a): The hidden cardiovascular risk
Syed Raza, Awali Hospital, Bahrain